Form 8-K - Current report:
SEC Accession No. 0001564590-22-027326
Filing Date
2022-08-02
Accepted
2022-08-02 06:31:46
Documents
15
Period of Report
2022-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-8k_20220802.htm   iXBRL 8-K 54761
2 EX-99.1 d305711dex991.htm EX-99.1 1000090
3 GRAPHIC g305711logo.jpg GRAPHIC 14845
4 GRAPHIC ghiyziu143k1000001.jpg GRAPHIC 2155
  Complete submission text file 0001564590-22-027326.txt   1252891

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idxx-20220802.xsd EX-101.SCH 5681
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20220802_lab.xml EX-101.LAB 19590
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20220802_pre.xml EX-101.PRE 11634
9 EXTRACTED XBRL INSTANCE DOCUMENT idxx-8k_20220802_htm.xml XML 3594
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 221126813
SIC: 2835 In Vitro & In Vivo Diagnostic Substances